Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 7/20 | 1.00 |
| ▸ | ACHE | P22303 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL635130 | 0.94 | TSHR (0.90) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL1396 | 0.89 | TSHR (0.78) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL3844920 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL2381051 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL5201173 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL5289451 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL31055057 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL16959208 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL29277770 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 | |
| SCHEMBL810499 | 0.84 | TSHR (0.71) | TSHRACHEHSD17B10CYP19A1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117160452-B | Supported iridium-indium bimetallic catalyst for aromatic nitro reduction methylation and preparation method and application thereof | 浙江大学衢州研究院 | 2025-04-25 | — | — | CN | claimed |
| CN-112724349-B | Polymer and use thereof | 立邦涂料（中国）有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-116693433-B | Synthesis method of alkyl substituted thiophenol | 济南悟通生物科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-117160452-A | Supported iridium-indium bimetallic catalyst for aromatic nitro reduction methylation and preparation method and application thereof | 浙江大学衢州研究院 | 2023-12-05 | — | — | CN | claimed |
| CN-114507252-B | Novel method for synthesizing arylsilane compound | 广西大学 | 2023-10-27 | — | — | CN | claimed |
| CN-116693433-A | Synthesis method of alkyl substituted thiophenol | 济南悟通生物科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-113019393-B | Platinum nano catalyst, preparation method thereof and method for synthesizing aromatic amine by selective hydrogenation of aromatic nitro compound | 郑州轻工业大学 | 2023-07-04 | — | — | CN | claimed |
| CN-113019393-A | Platinum nano catalyst, preparation method thereof and method for synthesizing aromatic amine by selective hydrogenation of aromatic nitro compound | 郑州轻工业大学 | 2021-06-25 | — | — | CN | claimed |
| US-10786805-B2 | Cadmium sulfide quantum dots | NORTHWESTERN UNIVERSITY (US) | 2020-09-29 | — | — | US | claimed |
| CN-107118161-B | Synthesis method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid | 湖北工业大学 | 2019-12-31 | — | — | CN | claimed |
| US-20160288106-A1 | CADMIUM SULFIDE QUANTUM DOTS | UNITED STATES DEPARTMENT OF ENERGY | 2016-10-06 | — | — | US | claimed |
| WO-2016153989-A1 | CADMIUM SULFIDE QUANTUM DOTS | NORTHWESTERN UNIVERSITY (US) | 2016-09-29 | — | — | WO | claimed |
| CN-105399632-A | Synthetic method for 1,5-bis(chloromethyl)-3-fluorobenzene | UNIV CHANGZHOU | 2016-03-16 | — | — | CN | claimed |
| US-7595424-B2 | Method for producing aromatic amines or aliphatic amino alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2009-09-29 | — | — | US | claimed |
| CN-100509750-C | Process for continuously preparing nitro-xylene isomer monomer | GANSU YINGGUANG CHEMICAL INDUS (CN) | 2009-07-08 | — | — | CN | claimed |
| CN-1944393-A | Process for continuously preparing nitro-xylene isomer monomer | YINGUANG CHEMICAL INDUSTRY GRO (CN) | 2007-04-11 | — | — | CN | claimed |
| EP-1037873-B1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | CONSORTIUM ELEKTROCHEM IND (DE) | 2001-08-22 | — | — | EP | claimed |
| US-6211410-B1 | PARTIALLY HYDROGENATING ORGANIC NITRO COMPOUND IN PRESENCE OF ORGANIC BASE OR AMMONIA, TRIVALENT PHOSPHORUS COMPOUND AND HYDROGENATION CATALYST | Consortium für elektrochemische Industrie GmbH (DE) | 2001-04-03 | — | — | US | claimed |
| EP-1037873-A1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | Consortium für elektrochemische Industrie GmbH (DE) | 2000-09-27 | — | — | EP | claimed |
| WO-1999028289-A1 | METHOD FOR PRODUCING ORGANIC HYDROXYLAMINES | Consortium für elektrochemische Industrie GmbH (DE) | 1999-06-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10786805-B2 | Cadmium sulfide quantum dots | AS3MT, TST, SQOR | TSHR 2865/4885ACHE 689/4885HSD17B10 1916/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.